US Patent

US9889144 — Abiraterone acetate formulation and methods of use

Formulation · Assigned to Iceutica Inc · Expires 2034-03-17 · 8y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a formulation of abiraterone acetate and methods for producing and using such compositions, including unit dosage forms.

USPTO Abstract

Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.

Drugs covered by this patent

chembl-chembl271227 (ABIRATERONE ACETATE)

Patent Metadata

Patent number: US9889144
Jurisdiction: US
Classification: Formulation
Expires: 2034-03-17
Drug substance claim: No
Drug product claim: Yes
Assignee: Iceutica Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.